Related Experiment Video
Updated: Jul 19, 2026
12:55
Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries
Published on: January 17, 2015
Harnessing phage and ribosome display for antibody optimisation
Patrick Dufner1, Lutz Jermutus, Ralph R Minter
1Cambridge Antibody Technology, Milstein Building, Granta Park, Cambridge CB1 6GH, UK.
Trends in Biotechnology
|September 27, 2006
Summary
Phage and ribosome display are powerful tools for discovering and optimizing therapeutic antibodies. These methods efficiently generate potent antibody drug candidates from large libraries, accelerating biopharmaceutical development.
Area of Science:
- Biotechnology
- Pharmaceutical Sciences
- Immunology
Background:
- Therapeutic antibodies are crucial in the biopharmaceutical industry.
- Developing safe and effective antibody leads is a competitive and complex process.
Purpose of the Study:
- To review and compare phage and ribosome display technologies for antibody discovery and optimization.
- To highlight the application of these display methods in generating potent antibody drug candidates.
Main Methods:
- Phage display technology for antibody library screening.
- Ribosome display technology for antibody library screening.
- Utilizing mutagenesis strategies (targeted, random, semi-rational) with display methods.
Main Results:
- Phage and ribosome display enable the search of billions of antibody variants.
- These technologies have successfully produced approved drugs and clinical candidates.
- Display methods combined with mutagenesis yield large panels of potent antibody leads.
Conclusions:
- Phage and ribosome display are highly effective for antibody optimization and drug candidate generation.
- These technologies offer efficient and successful routes for developing therapeutic antibodies.
- The review provides insights into exploiting display technologies for biopharmaceutical advancement.
